Novartis Consumer Health, Inc. creates, develops, and manufactures products that restore, maintain, and improve the health and well-being. It offers various over-the-counter products, including mineral supplements, topical antifungal agents, systemic and topical analgesic, antacids, anti inflammatory pain relief gel, and antifungal products; and products for cold sore treatment, overnight laxative, skin irritation treatment, adult gas relief, smoking cessation, nasal decongestant, adult cold and flu, skin care, and pediatric cough and cold. The company also provides contact lenses and lens care products. In addition, it involves in the research, development, and commercialization of pet and ...
200 Kimball Drive
Parsippany, NJ 07054-0622
Novartis Consumer Health, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013
Feb 7 13
Novartis Consumer Health, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
Novartis Consumer Health, Inc. Announces Voluntarily Recall of Select Lots of Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups Manufactured in the United States Before December 2011
Jan 31 13
Novartis Consumer Health, Inc. announced that it is voluntarily recalling certain lots of Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups that were manufactured in the United States before December 2011. The company has decided to issue a voluntary recall to consumers, retail customers and wholesalers in the US because the child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place. The company received four adverse events related to this issue on bottles of Triaminic(R) Syrups. There were no reports of adverse events related to this specific issue for Theraflu Warming Relief(R) Syrups. Triaminic(R) Syrups and Theraflu Warming Relief(R) Syrups continue to be safe and effective when used as directed on the package label. The products being recalled were produced at the Novartis Consumer Health manufacturing facility in Lincoln, Nebraska prior to the voluntary suspension of operations and shipments at the facility in December 2011. A consumer complaint in the US in late November 2012 triggered an internal investigation by Novartis Consumer Health that determined a voluntary recall was in the best interest of consumers.